amfenac has been researched along with Uveitis, Posterior in 1 studies
amfenac: RN given refers to parent cpd; structure
amfenac : An oxo monocarboxylic acid that is benzophenone in which one of the phenyl groups is substituted by an amino group and a carboxymethyl group at position 2 and 3, respectively. The corresponding carboxamide, nepafenac, is a prodrug of amfenac and is used for the treatment of pain and inflammation following cataract surgery.
Uveitis, Posterior: Inflammation of the choroid as well as the retina and vitreous body. Some form of visual disturbance is usually present. The most important characteristics of posterior uveitis are vitreous opacities, choroiditis, and chorioretinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nepafenac (0." | 1.43 | Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye. ( Chastain, JE; Chemuturi, NV; Curtis, MA; Dahlin, DC; Gadd, ME; Kapin, MA; Markwardt, KL; Sanders, ME, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chastain, JE | 1 |
| Sanders, ME | 1 |
| Curtis, MA | 1 |
| Chemuturi, NV | 1 |
| Gadd, ME | 1 |
| Kapin, MA | 1 |
| Markwardt, KL | 1 |
| Dahlin, DC | 1 |
1 other study available for amfenac and Uveitis, Posterior
| Article | Year |
|---|---|
Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Chromatography, High Pressure L | 2016 |